SCHEMBL30850465

SCHEMBL30850465

CN(CCNC(=O)OC(C)(C)C)c1ccc(N)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 1/20 0.49
SKP1 P63208 1/20 0.49
SKP2 Q13309 1/20 0.49
SUV39H2 Q9H5I1 2/20 0.43
CA1 P00915 8/20 0.42
CA2 P00918 8/20 0.42
CA12 O43570 5/20 0.42
CA9 Q16790 5/20 0.42
MALT1 Q9UDY8 1/20 0.41
IDO1 P14902 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 2/20 0.40
SLC22A2 O15244 1/20 0.40
SLC22A1 O15245 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
ACHE P22303 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257374 0.91 TDP1 (0.48) CKS1BSKP1SKP2CA1CA2
SCHEMBL29066264 0.86 CKS1B (0.49) CKS1BSKP1SKP2SUV39H2CA1
SCHEMBL1998123 0.83 CKS1B (0.53) CKS1BSKP1SKP2SUV39H2CA1
SCHEMBL30850514 0.82 MAPT (0.50) CKS1BSKP1SKP2SUV39H2LMNA
SCHEMBL15707597 0.80 CYP1A1 (0.41) CKS1BSKP1SKP2SUV39H2CA1
SCHEMBL29024510 0.79 ALDH1A1 (0.45) TDP1LMNASLC22A2SLC22A1ALDH1A1
SCHEMBL15092378 0.78 AAK1 (0.48) CKS1BSKP1SKP2SUV39H2CA1
SCHEMBL9100684 0.78 CKS1B (0.52) CKS1BSKP1SKP2CA1CA2
SCHEMBL23329003 0.77 GBA1 (0.42) TDP1ALDH1A1TSHRMAPK1MAOA
SCHEMBL8993963 0.77 MMP14 (0.38) TDP1LMNAALDH1A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024244888-A1 9-MEMBERED HETEROARYL COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING 9-MEMBERED HETEROARYL COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 广东弘烨医药科技有限公司 2024-12-05 WO disclosed
WO-2024102970-A1 COMPOUNDS FOR MODULATING SYK ACTIVITY AND E3 UBIQUITIN LIGASE ACTIVITY Kronos Bio, Inc. (US) 2024-05-16 WO disclosed